NanoViricides, Inc.
NNVC
$1.26
$0.010.80%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.89% | 2.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.00% | 32.47% | |||
| Operating Income | 35.00% | -32.47% | |||
| Income Before Tax | 35.16% | -32.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 35.16% | -32.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 35.16% | -32.72% | |||
| EBIT | 35.00% | -32.47% | |||
| EBITDA | 37.31% | -35.05% | |||
| EPS Basic | 38.99% | -18.44% | |||
| Normalized Basic EPS | 38.95% | -18.45% | |||
| EPS Diluted | 38.99% | -18.44% | |||
| Normalized Diluted EPS | 38.95% | -18.45% | |||
| Average Basic Shares Outstanding | 6.24% | 12.06% | |||
| Average Diluted Shares Outstanding | 6.24% | 12.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||